Latest news
ZVRA Maintained by Citizens -- Price Target Raised to $28.00 - GuruFocusGuruFocus · Thu, 06 Aug 2026 14:26:30 GMTZevra Therapeutics Inc (ZVRA) (Q2 2026) Earnings Call Highlights - GuruFocusGuruFocus · Thu, 06 Aug 2026 06:10:05 GMTIs Zevra Therapeutics Inc (ZVRA) Underperforming After Q2 2026 E - GuruFocusGuruFocus · Thu, 06 Aug 2026 00:22:14 GMTZBRA Maintains by Citigroup -- Price Target Raised to $396 - GuruFocusGuruFocus · Wed, 05 Aug 2026 23:04:19 GMTZBRA Maintained by TD Cowen -- Price Target Raised to $450 - GuruFocusGuruFocus · Wed, 05 Aug 2026 22:58:52 GMTZBRA Maintained by Truist Securities -- Price Target Raised to $355 - GuruFocusGuruFocus · Wed, 05 Aug 2026 20:27:27 GMTZBRA Maintained by Keybanc -- Price Target Raised to $430 - GuruFocusGuruFocus · Wed, 05 Aug 2026 17:00:50 GMTZBRA Maintained and Target Raised by Barclays to $410 - GuruFocusGuruFocus · Wed, 05 Aug 2026 16:11:53 GMT